+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer



Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer



Cancer Research 60(24): 6859-6863



In recent years, significant effort has been made to identify genes that influence breast cancer risk. Because the high-penetrance breast cancer susceptibility genes BRCA1 and 2 play a role only in a small fraction of breast cancer cases, understanding the genetic risk of the majority of breast cancers will require the identification and analysis of several lower penetrance genes. The estrogen-signaling pathway plays a crucial role in the pathophysiology of breast cancer; therefore, polymorphism in genes involved in this pathway is likely to influence breast cancer risk. Our detailed analysis of gene expression profiles of estrogen- and 4-OH-tamoxifen-treated ZR75-1 breast cancer cells identified members of the sulfotransferase 1A (SULT1A) phenol sulfotransferase family as downstream targets of tamoxifen. On the basis of the induction of SULT1A by 4-OH-tamoxifen and the known inherited variability in SULT1A enzymatic activity, we hypothesized that polymorphism in sulfotransferase genes might influence the risk of breast cancer. Using an RFLP that distinguishes an arginine to histidine change in exon 7 of the SULT1A1 gene, we characterized SULT1A1 genotypes in relation to breast cancer risk. An analysis of 444 breast cancer patients and 227 controls revealed no effect of SULT1A1 genotype on the risk of breast cancer (P = 0.69); however, it did appear to influence the age of onset among early-onset affected patients (P = 0.04). Moreover, individuals with the higher activity SULT1A1*1 allele were more likely to have other tumors in addition to breast cancer (P = 0.004; odds ratio, 3.02; 95% confidence interval, 1.32, 8.09). The large number of environmental mutagens and carcinogens activated by sulfotransferases and the high frequency of the SULT1A1*1 allele in human populations warrants additional studies to address the role of SULT genes in human cancer.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973237

Download citation: RISBibTeXText

PMID: 11156380


Related references

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. British Journal of Cancer 92(5): 857-866, 2005

Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer. Bmc Cancer 9: 13, 2009

Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. International Journal of Gynecological Cancer 16(Suppl. 2): 497, 2006

Triple negative breast cancer and phosphatase and tensin homolog loss are predictors of BRCA1 germline mutations in women with early onset and familial breast cancer, but not in women with isolated late-onset breast cancer. 2012

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Breast Cancer Research 14(6): R142, 2012

Increased urinary androgen excretion is a hormonal abnormality detectable before the clinical onset of breast cancer. Cancer Detection and Prevention 6(4-5): 435-438, 1983

MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan. Annals of Surgical Oncology 24(2): 603-610, 2017

The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncology Letters 3(4): 875-878, 2012

Correlation of polymorphism rs1563828 in MDM4 gene with breast cancer risk and onset age. Zhonghua Wai Ke Za Zhi 50(1): 53-56, 2012

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl.): 1s-106s, 1996

Hormonal regulation of TGF-beta-expression in breast cancer. Motta, M, Serio, M International Congress Series; Sex hormones and antihormones in endocrine dependent pathology: Basic and clinical aspects 337-346, 1994

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Research 68(1): 22-25, 2008

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Research and Treatment 119(1): 87-93, 2010

Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer. International Journal of Molecular Sciences 15(1): 712-724, 2014

Hormonal regulation in breast cancer from cell lines to patients. Presse Medicale 23(26): 1211-1216, 1994